Trials / Unknown
UnknownNCT02700633
Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- Royal Sussex County Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pacemaker requirement in the immediate post procedure phase following TAVI is approximately 20% depending on device type and patient characteristics. There is a signal from recent studies suggesting increased risk of sudden cardiac / unexplained death in the first 30-60 days. This study aims to address whether there is a mortality advantage to having a pacemaker in the short term
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pacemaker |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-07-01
- First posted
- 2016-03-07
- Last updated
- 2016-03-07
Source: ClinicalTrials.gov record NCT02700633. Inclusion in this directory is not an endorsement.